JAMA Network

•

チャンネル • 21個の番組

医学

医学

アップデート：毎週
医学

医学

アップデート：隔週
医学

医学

2025/09/04
医学

医学

アップデート：隔月
医学

医学

アップデート：隔月
医学

医学

アップデート：毎週
医学

医学

アップデート：毎月

3日前

Pharmaceutical Pricing: JAMA Talks With Mark Cuban

Mark Cuban, entrepreneur, investor, and cofounder of the Mark Cuban Cost Plus Drug Company, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the role of pharmacy benefit managers, insurance formularies, and opaque pricing practices that shape how most Americans access prescription drugs. Hear why he thinks doctors are the good guys in a broken system. Related Content: Pharmaceutical Pricing—JAMA Talks With Mark Cuban

3日前

•

33分
4日前

Medications for Opioid Use Disorder, Withdrawal, and Overdose

Opioid use disorder is the third most prevalent substance use disorder worldwide. Author Alexander Walley, MB, MSc, of Boston Medical Center and Boston University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the efficacy, safety, and practical considerations of treating patients with medications for opioid use disorder, opioid withdrawal, and opioid overdose. Related Content: Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose

4日前

•

24分
2月2日

Ovarian Cancer Prevention With Opportunistic Fallopian Tube Removal

Ovarian cancer may be prevented with removal of the fallopian tubes during pelvic or select abdominal surgery in eligible women. This procedure, opportunistic salpingectomy, can be offered to more eligible women. Author Jurgen M. Piek, MD, PhD, of the Catharina Cancer Institute discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content: Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma

2月2日

•

18分
2月6日

Understanding COVID-19 Vaccine–Associated Myocarditis

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis." Related Content: Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis

2月6日

•

5分
2日前

ICE Raids Are Jeopardizing Health Care Access

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "US Patients Getting ICE-d-Out of Health Care." Related Content: US Patients Getting ICEd-Out of Health Care

2日前

•

6分
1月26日

IgA Nephropathy in Adults

IgA nephropathy is a chronic kidney disease involving deposition of IgA-containing immune complexes in the glomerulus, which often causes kidney failure within 10 to 20 years. Author Michelle Marie O'Shaughnessy, MB, BCh, BAO, MS, of Galway University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, treatment, and prognosis of IgA nephropathy in adults. Related Content: IgA Nephropathy in Adults

1月26日

•

27分
1月30日

What's Next in Weight-Loss Drugs?

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year." Related Content: Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year

1月30日

•

6分
1月21日

Restless Legs Syndrome

Restless legs syndrome is a sleep-related neurologic disorder that causes an overwhelming urge to move the limbs, which can cause substantial sleep disturbance. Author John W. Winkelman, MD, PhD, of Harvard Medical School joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, and treatment of restless legs syndrome. Related Content: Restless Legs Syndrome

1月21日

•

23分
2025/12/17

WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content: World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

2025/12/17

•

34分
1月12日

A Conversation About the FDA's Regulation of Mifepristone

Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD, MS, from Johns Hopkins discusses this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content: The US Food and Drug Administration's Regulation of Mifepristone Politics, Science, and the Future of FDA Drug Regulation

1月12日

•

21分

JAMA Network™ is a collection of 13 medical journals spanning specialties and general medicine. JN podcasts include Editor summaries, author interviews, conversations, clinical updates and more.

Webサイト

JAMA Network

トップ番組

トップエピソード

番組について